An update on the development of concepts, diagnostic criteria, and challenging issues for neuroendocrine neoplasms across different digestive organs

被引:9
作者
Couvelard, Anne [1 ]
Cros, Jerome [1 ]
机构
[1] Univ Paris Cite, Bichat & Beaujon AP HP Hosp, ENETS Ctr Excellence, Dept Pathol, 46 Rue Henri Huchard, F-75018 Paris, France
关键词
Digestive neuroendocrine tumour; Neuroendocrine carcinoma; Classification; Biomarkers; ACINAR-CELL CARCINOMA; GRADE; 3; PROGNOSTIC-FACTORS; PROTEIN-1; INSM1; TUMORS; EXPRESSION; KI-67; G3; SYNAPTOPHYSIN; HETEROGENEITY;
D O I
10.1007/s00428-022-03306-7
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Digestive neuroendocrine neoplasms (NENs) are a group of heterogeneous neoplasms found throughout the digestive tract, with different behaviour and genetic background. In the last few years, nomenclature and WHO/UICC classifications of digestive NENs have changed, and molecular classifications have emerged, especially in pancreatic locations. Increasing patho-molecular details are needed to diagnose the different categories of NEN, including the use of helpful immunohistochemical markers. In this review, we address these topics in three successive chapters. We first briefly review recent updates in classifications, discuss important grading and proliferating issues and advances in the molecular understanding of NEN. Then, we provide an update on diagnosis, including the most important differential diagnoses of NEN, with a focus on high-grade neoplasms and mixed tumours. Finally, we highlight a variety of currently used and next-generation predictive and prognostic biomarkers as well as biomarkers of tumour origin and describe some site specificities of gastrointestinal NEN. We specifically focus on biomarkers available to pathologists with the potential to change the way patients with NEN are diagnosed and treated.
引用
收藏
页码:1129 / 1148
页数:20
相关论文
共 125 条
  • [1] Gastrointestinal neuroendocrine tumors in 2020
    Ahmed, Monjur
    [J]. WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 12 (08) : 791 - 807
  • [2] Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma
    Ali, Abir Salwa
    Gronberg, Malin
    Federspiel, Birgitte
    Scoazec, Jean-Yves
    Hjortland, Geir Olav
    Gronbaek, Henning
    Ladekarl, Morten
    Langer, Seppo W.
    Welin, Staffan
    Vestermark, Lene Weber
    Arola, Johanna
    Osterlund, Pia
    Knigge, Ulrich
    Sorbye, Halfdan
    Grimelius, Lars
    Janson, Eva Tiensuu
    [J]. PLOS ONE, 2017, 12 (11):
  • [3] The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging
    Amin, Mahul B.
    Greene, Frederick L.
    Edge, Stephen B.
    Compton, Carolyn C.
    Gershenwald, Jeffrey E.
    Brookland, Robert K.
    Meyer, Laura
    Gress, Donna M.
    Byrd, David R.
    Winchester, David P.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2017, 67 (02) : 93 - 99
  • [4] The High-grade (WHO G3) Pancreatic Neuroendocrine Tumor Category Is Morphologically and Biologically Heterogenous and Includes Both Well Differentiated and Poorly Differentiated Neoplasms
    Basturk, Olca
    Yang, Zhaohai
    Tang, Laura H.
    Hruban, Ralph H.
    Adsay, Volkan
    McCall, Chad M.
    Krasinskas, Alyssa M.
    Jang, Kee-Taek
    Frankel, Wendy L.
    Balci, Serdar
    Sigel, Carlie
    Klimstra, David S.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (05) : 683 - 690
  • [5] Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you?
    Bellizzi, Andrew M.
    [J]. HUMAN PATHOLOGY, 2020, 96 : 8 - 33
  • [6] Pathologic Considerations in Gastroenteropancreatic Neuroendocrine Tumors
    Bellizzi, Andrew M.
    [J]. SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2020, 29 (02) : 185 - +
  • [7] SATB2 in neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas
    Bellizzi, Andrew M.
    [J]. HISTOPATHOLOGY, 2020, 76 (02) : 251 - 264
  • [8] Immune checkpoint markers in gastroenteropancreatic neuroendocrine neoplasia
    Boesch, Florian
    Bruewer, Katharina
    Altendorf-Hofmann, Annelore
    Auernhammer, Christoph J.
    Spitzweg, Christine
    Westphalen, C. Benedikt
    Boeck, Stefan
    Schubert-Fritschle, Gabriele
    Werner, Jens
    Heinemann, Volker
    Kirchner, Thomas
    Angele, Martin
    Knoesel, Thomas
    [J]. ENDOCRINE-RELATED CANCER, 2019, 26 (03) : 293 - 301
  • [9] High-Grade Progression Confers Poor Survival in Pancreatic Neuroendocrine Tumors
    Botling, Johan
    Lamarca, Angela
    Bajic, Duska
    Norlen, Olov
    Lonngren, Vincent
    Kjaer, Josefine
    Eriksson, Barbro
    Welin, Staffan
    Hellman, Per
    Rindi, Guido
    Skogseid, Britt
    Crona, Joakim
    [J]. NEUROENDOCRINOLOGY, 2020, 110 (11-12) : 891 - 898
  • [10] Brierley JD., 2017, TNM CLASSIFICATION M